Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments

BACKGROUND: Inhaled corticosteroid/long-acting β(2)-agonist combinations and/or long-acting muscarinic antagonists are recommended first-line therapies for preventing chronic obstructive pulmonary disease (COPD) exacerbation. Comparative effectiveness of budesonide/formoterol combination (BFC, an in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Chron Obstruct Pulmon Dis
Hlavní autoři: Trudo, Frank, Kern, David M, Davis, Jill R, Tunceli, Ozgur, Zhou, Siting, Graham, Emma L, Strange, Charlie, Williams, Setareh A
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4592033/
https://ncbi.nlm.nih.gov/pubmed/26451101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S90658
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky